Introduction
Amyloid beta (Aβ), a polypeptide composed of 39 -43 amino acids, is a causative agent of neurodegenerative disorder, Alzheimer's disease (AD). 1, 2 Aβ is known to aggregate spontaneously into β-sheet-rich fibrils. 3 These water-insoluble fibrillar aggregates have neurotoxic properties. Recent studies have shown that soluble Aβ oligomers, which are an intermediate stage of Aβ fibrillation have more toxic properties than the fibrillar state. 4, 5 The formation of Aβ aggregates, such as oligomers and fibrils, is considered to be a trigger for AD neurodegeneration by affecting brain nerve cells. Conformation analysis of Aβ is therefore important for early recognition of AD.
There are several published reports related to Aβ detection. Aβ detection has been carried out mainly using enzyme-linked immunosorbent assays (ELISA) with Aβ antibody. 6, 7 Specific detection methods for Aβ oligomers using oligomer antibodies have also been reported recently, 8, 9 making it possible to determine the concentration of respective Aβ comformations. However, using ELISA is believed to be unsuitable for rapid Aβ-conformation analysis, because these assays take several hours for signal detection. Alternatively, polyacrylamide gel electrophoresis (PAGE)/western blotting is available for Aβ-conformation analysis. 10 However, this method also takes a few hours for detection, and it is possible to cause dissociation of Aβ aggregates during electrophoresis. 11 These methods used to detect Aβ in ordinal amyloid studies are considered to be suitable for a quantitative analysis such as size and amounts of Aβ aggegates, but not appropriate for a rapid estimation of the Aβ-conformation. Recently, several methods concerning the rapid detection of Aβ were reported. Using two kinds of Aβ antibody modified with different fluorescent chemicals, Santos et al. reported the detection of Aβ aggregates based on fluorescence resonance energy transfer (FRET), 12 which enables to detect the Aβ oligomer and fibril within 90 min. However, this method requires the use of a fluorescence spectrometer equipped a FRET signal detector, and is thought not to be an easy-to-use approach. Another oligomer detection method using a peptide that recognizes the Aβ oligomer specifically was reported. 13 This method allowed Aβ oligomer detection within 1 h, while the detection of fibril was not possible. Therefore, the development of a simple and rapid detection method of Aβ aggregates, including both oligomers and fibrils, is required.
In this study, we aimed to develop a novel, rapid method for determining the Aβ-conformation. A detection system that estimates existence of Aβ aggregates, but not an ordinal quantitative Aβ detection method, was developed. Our method enabled determining whether the Aβ-conformation was a monomer or aggregate state within 1 h using Aβ antibodies and gold nanoparticles (AuNPs). We believe that this method may also be used to screen for various amyloid peptides other than Aβ.
Experimental

Reagents and chemicals
Aβ (1 -42) was purchased from Peptide Institute (Osaka, Japan), phenol red-free Ham's F12 medium from Biosource (Rockville, MD), mouse monoclonal Aβ antibody (6E10) from Covance (Berkeley, CA), and BCA protein assay reagent from Thermo Scientific (Roskilde, Denmark). AuNPs, 200 nm in diameter, were purchased from British Biocell International (UK), and a PBS solution (137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4) from Nippon Gene (Japan). Bovine serum albumin (BSA) was obtained from Sigma Chemical Company (St Louis, MO), and a protein molecular weight marker from Bio-Rad (Hercules, CA). All other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Preparation of Aβ samples
Seed-free Aβ monomers were prepared according to a previous † To whom correspondence should be addressed. E-mail: msakono@riken.jp Notes report. 14 Briefly, synthetic Aβ42 was dissolved in a 0.1% ammonia water solution at 500 μM, and then centrifuged at 100000 rpm for 3 h at 4 C using the Optima TL Ultracentrifuge (Beckman Instruments, Fullerton, CA) to remove undissolved peptide aggregates. The supernatant was collected and stored in aliquots at -80 C. Before use, the aliquots were thawed on ice and diluted with PBS. The Aβ oligomer was prepared according to Costantini et al. 15 Briefly, the Aβ42 monomer stock was diluted to 100 μM in an ice-cooled phenol red-free Ham's F12 medium, and then incubated at 37 C for 24 h. The oligomer solution was centrifuged at 15000 rpm for 15 min, followed by collection of the supernatant containing soluble Aβ oligomer. Aβ fibrils were prepared by incubating the Aβ42 monomer stock, diluted to 100 μM in PBS, for 24 h at 50 C. The solution was centrifuged at 15000 rpm for 15 min to remove excess monomers and oligomers and the precipitates were collected as Aβ fibrils. The concentration of the Aβ samples was measured using the BCA protein assay kit according to the manufacturer's instructions.
Immobilization of Aβ antibodies on AuNP
A 100-μl aliquot of AuNPs obtained from BBI was added to a microtube, and then centrifuged at 10000 rpm for 10 min. The supernatant was removed, and AuNP precipitates remaining in the tubes were suspended to 100 μl in 10-times diluted PBS including the 50 nM Aβ antibody (6E10), followed by incubation for 1 h at room temperature. After incubation, 100 ml of 10-times diluted PBS containing 5 wt% BSA was added to the microtube, followed by incubation for 30 min. The microtube was then centrifuged at 8000 rpm for 15 min, and the supernatant removed. AuNPs precipitates were re-suspended in 1× PBS and used for further study.
Confirmation of Aβ antibodies immobilization on AuNP
A 10-μl aliquot of AuNPs modified with Aβ antibody prepared in above step was transferred to a new microtube. The AuNPs were centrifuged, and the supernatant was removed. The AuNPs were re-suspended in 10-μl of SDS loading buffer containing 10% β-mercaptoethanol and then denatured at 98 C for 3 min. Following separation for 60 min by SDS-PAGE on 10 -20% Tris-glycine gels at a constant current of 20 mA, the total proteins on the gels were detected with Coomassie Brilliant blue R-250.
DLS experiments were performed using Zetasizer Nano instrument (Malvern Instruments, Worcestershire, UK). A 50-μl aliquot of solution containing AuNPs was transferred to a 1 × 1 cm fluorescence cuvette (Hellma, Müllheim, Germany) and measured using a 4-mW He-Ne laser (633 nm wavelength) with a fixed detector angle of 173 , under temperature-controlled conditions at 25 C with a tolerance of ±0.02 C.
Aβ detection using AuNPs modified with Aβ antibodies
The microtubes containing AuNPs modified with the Aβ antibody were centrifuged at 8000 rpm for 15 min, and the supernatant was removed. An appropriate concentration of the Aβ samples was added to the microtubes, and the precipitates of AuNPs were suspended by pipetting. After incubation for 1 h at 37 C, the samples were observed by naked eye and the UV spectrum measured by UV-Vis spectroscopy. The absorbance of AuNPs over the range 400 to 700 nm was measured using Cary-50 UV-Vis spectrophotometer (Varian). Firstly, the preparation of AuNP modified with Aβ antibodies was investigated. When AuNPs untreated with BSA were suspended in a 1× PBS solution in a microtube, they adsorbed to the polypropylene microtube wall (Fig. 2a) . This nonspecific adsorption between polypropylene and AuNPs is believed to be caused by an increase in the surface hydrophobicity of AuNPs by salt contained in the PBS. 16, 17 The absorption spectra of AuNPs remained decreased compared to AuNPs in water even when the Aβ antibody concentration was increased (Fig. 2b) . On the other hand, when AuNPs treated with BSA were suspended in a 1× PBS solution, their absorbance values were much higher than those of untreated AuNP (Fig. 2c) . Moreover, nonspecific adsorption of AuNPs to the microtube wall was not observed (Fig. 2a) . This result indicates that BSA is an effective additive for stabilization of AuNPs dispersed in a buffer solution.
Results and Discussion
We next confirmed immobilization of the Aβ antibody on AuNPs using SDS-PAGE. Figure 3 shows bands of protein immobilized on the surface of AuNP. As shown in the figure, the Aβ antibody was observed in the lane of AuNPs treated with BSA, supporting successful immobilization. On the other hand, no protein bands were indicated in the lane of AuNPs untreated with BSA. This might be because only a small amount of AuNPs modified with the Aβ antibody was present in the 1× PBS solution due to adsorption onto the microtube. To further confirm antibody immobilization, the diameter of these AuNPs modified with the Aβ antibody was measured by DLS analysis (data not shown). The results show that the diameter of AuNPs treated with BSA and untreated AuNPs were 37.0 and 23.1 nm, respectively. Since the length of the IgG type antibody is approximately 8 nm, 18 this result also suggests that multiple Aβ antibodies are immobilized on the AuNP surface. These results indicate that Aβ antibodies are adsorbed onto the AuNP surface, resulting in the formation of complexes of AuNPs modified with the Aβ antibody. The interaction of AuNPs modified with Aβ antibody after treatment with 5% BSA and Aβ in various conformation states was then examined (Fig. 4) . When 5 μM of the Aβ monomer was added to a PBS solution containing AuNPs and incubated at 37 C for 1 h, a significant change was not observed visually. The absorption spectrum also showed that the absorbance remained unchanged. In contrast, in the presence of the Aβ oligomer, red-colored precipitates were confirmed by the naked eye, and the absorption spectra showed a decrease in absorbance. Similarly, the addition of 5 μM Aβ fibrils induced the production of red-colored precipitates, although precipitation did not occur with 10 nM Aβ fibrils. This might be because the interaction between the Aβ antibodies and Aβ fibrils is weak since the fibrils have different hydrophobic properties than the oligomers. Therefore, the addition of Aβ fibrils at low concentrations may be insufficient to form precipitates. Our results indicates that Aβ aggregates, both oligomer and fibril, are able to be detected using AuNPs modified with the Aβ antibody within 1 h. Especially, this Aβ-conformation analysis is useful for simple and rapid detection of Aβ aggregates, because this method enables to determine the Aβ-conformation with naked-eye.
Interestingly, precipitates formed by the addition of oligomers or fibrils maintained a red color that originated from the surface plasmon band of AuNPs. The aggregation of AuNPs is generally known to cause a characteristic transition in solution color from red to purple-violet. 17 Therefore, we speculate that the production of huge complexes between Aβ aggregates and AuNPs, rather than aggregate formation of AuNPs, results in precipitation. 
Conclusions
AuNPs modified with Aβ antibody were prepared for a Aβ-conformation assay. The treatment of AuNPs with BSA caused a reduction of the nonspecific adsorption to the microtube due to an increase of the AuNPs dispersion stability. Red-colored precipitates were observed by the naked eye in the presence of Aβ aggregates such as oligomers and fibrils, while no change was observed in the presence of Aβ monomers. Our results suggest that AuNPs modified with the Aβ antibody are effective for the simple and rapid detection of Aβ aggregates that are causative agents of AD. 
